{"Title": "Author's reply to Blake", "Year": 2016, "Source": "BMJ (Online)", "Volume": "352", "Issue": null, "Art.No": null, "PageStart": null, "PageEnd": null, "CitedBy": 0, "DOI": "10.1136/bmj.i1347", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84960977520&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Amoxicillin", "Anti-Bacterial Agents", "Cardiovascular Diseases", "Clarithromycin", "Helicobacter Infections", "Helicobacter pylori", "Humans", "Respiratory Tract Infections"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-84960977520", "SubjectAreas": [["Medicine (all)", "MEDI", "2700"]], "AuthorData": {"7102513915": {"Name": "Wong I.C.K.", "AuthorID": "7102513915", "AffiliationID": "60016379", "AffiliationName": "Research Department of Practice and Policy, UCL School of Pharmacy"}}}